Strut Health review

Choose medical care for a medical question

Strut is relevant when a qualified clinician is considering a prescription and has explained why compounded treatment may be appropriate. It is a different purchase from a food diary, prepared meals or a behavioral program. Its semaglutide service describes an injectable and a buccal lozenge with consultations and shipping included. ^[1] That can look convenient. The catch is that easier ordering does not settle whether the proposed preparation is the right treatment or provide all the support needed around eating and daily life.

A lozenge changes the evidence question

An injection and a lozenge should not be treated as the same product simply because both use the semaglutide name. The important question for the prescriber is what evidence and clinical rationale apply to the actual preparation. A needle-free format may be appealing without having the evidence base of the branded injection familiar from a weight-loss headline. Compounded medicines are not FDA-approved. ^[2]

Someone choosing a service mainly because of the format should pause at that distinction. Establish what approved alternatives are appropriate and what specific need compounding addresses. That is a treatment conversation. It cannot be resolved by a subscription discount or by the convenience of delivery.

The regulatory record affects the shortlist

FDA sent Strut a warning letter dated February 20, 2026 concerning misleading compounded-drug advertising and representations about the compounder. ^[3] The letter does not, by itself, establish what happened after the warning or determine the current status of every product. It does make clear why the actual pharmacy and preparation need to be identified on treatment documents.

Do not infer manufacturing responsibility from branding on a website. A platform, prescribing clinician and pharmacy have different responsibilities. A buyer should be able to understand who handles the medical decision, who prepares and dispenses the medicine and who can resolve a shipment problem. That clarity is more useful than a reassuring logo.

To understand the evidence behind this part of the decision, read our Behavioral coaching vs going it alone. The guide distinguishes a study result from the service being purchased.

Price the treatment and the rest of your support

Strut advertises $129 for a monthly injectable semaglutide vial and $199 for a 30-day buccal-lozenge supply, with physician consultations and shipping included. Final pricing follows consultation. ^[1] These are distinct advertised offers, rather than one guaranteed bill for every patient. Obtain the actual prescription, amount due and renewal terms before paying. Establish what happens if the clinician changes the plan or you need to stop before the next shipment.

Then consider what remains outside that purchase. If your difficulty is planning meals around reduced appetite, finding affordable food or keeping a manageable routine, ask what support is actually included. Messaging about a prescription is not automatically individual nutrition counseling. You may need a different service for that part of the week, and its cost belongs in the broader decision.

Keep the choice tied to the problem

Fay and Nourish are more relevant comparisons for personal nutrition counseling. WeightWatchers is more relevant if you want a food framework and group accountability. Neither comparison decides whether medication is appropriate. Strut fits only after the medical pathway is clear and its product and follow-up terms are acceptable.

A useful next step is a written treatment summary: preparation, pharmacy, follow-up route, recurring charge and cancellation timing. If those details remain unclear, keep comparing. The right service should make the plan easier to understand before it makes the purchase easier to complete.

For the next decision, use our Fay Nutrition review to compare the kind of support you would actually use.

Understanding the cost

Advertised compounded semaglutide costs are $129 for a monthly injectable vial or $199 for a 30-day buccal-lozenge supply, with physician consultations and shipping included. Consultation determines final pricing. Separate any additional nutrition-support cost from this medication purchase.